Keyphrases
Diabetes
100%
Endothelial Dysfunction
100%
Poly(ADP-ribose) Polymerase
100%
Myocardial Dysfunction
100%
Cardiac Dysfunction
50%
Beneficial Effects
33%
PARP Inhibitor (PARPi)
33%
Streptozotocin-induced
33%
Hyperglycemia
16%
Nephropathy
16%
Retinopathy
16%
Neuropathy
16%
Diabetic
16%
High Incidence
16%
Myocardial Infarction
16%
Vascular Reactivity
16%
PJ34
16%
Vascular Complications
16%
Thoracic Aorta
16%
Endothelium-dependent Vasodilation
16%
Poly (ADP-ribose) Polymerase Inhibition
16%
Severe Hyperglycemia
16%
Diabetic Cardiomyopathy
16%
Patients with Diabetes
16%
Cardiovascular Complications
16%
Diabetic Model
16%
Non-obese Diabetic
16%
Diastolic Dysfunction
16%
Hypertension Risk
16%
Induced Models
16%
Pharmacology, Toxicology and Pharmaceutical Science
Diabetes Mellitus
100%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase
100%
Endothelial Dysfunction
100%
Pathogenesis
25%
Hyperglycemia
25%
Streptozotocin
25%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
25%
Mouse
12%
Rat
12%
Enzyme
12%
Hypertension
12%
Retinopathy
12%
Complication
12%
Incidence
12%
Kidney Disease
12%
Heart Infarction
12%
Cardiovascular Disease
12%
Neuropathy
12%
N (5,6 Dihydro 6 Oxo 2 Phenanthridinyl) 2 Dimethylaminoacetamide
12%
Diabetic Cardiomyopathy
12%
Diastolic Dysfunction
12%
INIS
polymerases
100%
adp
100%
ribose
100%
pathogenesis
25%
hyperglycemia
25%
streptozotocin
25%
mice
12%
patients
12%
genetics
12%
enzymes
12%
rats
12%
losses
12%
risks
12%
vasodilation
12%
endothelium
12%
inhibition
12%
hypertension
12%
myocardial infarction
12%
aorta
12%